George Kemble, Director at Sagimet Biosciences Inc. (SGMT), sold 18,844 shares at $7.46 ($141K) on 2026-07-20, disclosed to the SEC on 2026-07-22.
Scheduled sale ($141k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SGMT | SELL | 2025-11-21 | $580K | — | Filing → |
| SGMT | SELL | 2024-07-25 | $150K | — | Filing → |
| SGMT | SELL | 2024-07-23 | $44K | — | Filing → |